Ortin Global

  • Market Cap: Micro Cap
  • Industry: Pharmaceuticals & Biotechnology
  • ISIN: INE749B01020
  • NSEID: ORTINGLOBE
  • BSEID: 539287
INR
15.61
1.12 (7.73%)
BSENSE

Dec 05

BSE+NSE Vol: 1.07 lacs

  • Price Points
  • Score
  • Mojo Parameters
  • Total Return
  • News and Corporate Actions
  • Key factors
  • Shareholding
  • Financials
  • CompanyCV
stock-summaryCompany CV
About Ortin Global Ltd stock-summary
stock-summary
Ortin Global Ltd
Micro Cap
Pharmaceuticals & Biotechnology
Ortin Laboratories Limited was incorporated in October, 1986 with a nominal capital of Rs 1 lakh to offer quality Drugs and Medicines to the suffering mankind. The Company is a leading and predominant Pharmaceutical Manufacturer of Drugs and Medicines in India. The company is engaged in manufacture of Pharma formulations. They manufacture a range of pharmaceutical formulations of tablets, capsules, syrups, dry powders, and ointments in India.
Company Coordinates stock-summary
Company Details
D No 1-8-B4 Ground Floor F3, HIG Block-4 Street No 3 Hyderabad Telangana : 500044
stock-summary
Tel:
stock-summary
info@ortinlabsindia.com
Registrar Details
Karvy Computershare Pvt Ltd, Plot No 17-24 , Near Image Hospital,, Reliance Cybervilae,Vithalrao Nagar,, Madhapur, Hyderabad
stock-summary Capital Structure
Capital Structure stock-summary
Present Equity Capital
INR 8.13 Cr
Number of Shares
81.31 Cr
Face Value
INR 10.0
Date
Number
of Shares(Cr)
Equity
Capital (Rs Cr)
Shares Added
Face Value (Rs)
Reason
12-Jan-2021
81.31
8.13
-8809008
10
scheme of arrangement-Cap.Reduction
13-Oct-2011
1.69
16.94
12240000
10
Amalgamation
13-Oct-2011
1.69
16.94
12240000
10
Amalgamation
27-Dec-2010
47
4.70
1030000
10
Allotment of Equity Shares To Promoter & Others
27-Dec-2010
47
4.70
1030000
10
Allotment of Equity Shares To Promoter & Others
31-Mar-2007
36.7
3.67
365000
10
Unspecified
31-Mar-2007
36.7
3.67
365000
10
Unspecified
stock-recommendation Shareholding
Shareholding Snapshotstock-summary
Shareholding Compare (%holding) stock-summary
Majority shareholders

Non Institution

Pledged Promoter Holdings

None

Mutual Funds

Held by 0 Schemes

FIIs

Held by 1 FIIs (1.68%)

Promoter with highest holding

Sanka Tandav Krishna (0.5%)

Highest Public shareholder

Suresh Gadalay (4.72%)

Individual Investors Holdings

90.85%

stock-summary Board of Directorsstock-summary
stock-summary
Management
Designation
Remuneration
S Murali Krishna Murthy
Managing Director
6.58 lacs
S Balaji Venkateswarlu
Director
5.41 lacs
S Srinivas Kumar
Whole Time Director & CFO
5.41 lacs
J R K Panduranga Rao
Chairman & Independent Directo
6.0 k
Gaddam Venkata Ramana
Director
0
Bhupathiraju S Raju
Director
0
B Gopal Reddy
Independent Director
6.0 k
Murali Krishna Rayaprolu
Independent Director
6.0 k
Pottur Sujatha
Independent Director
6.0 k
Harish Sharma
Company Secretary / Compliance
0
stock-recommendationRaw Materials
Raw Materials Dashboard stock-summary
Raw Materials
Amount(Rs Cr)
% of RM Cost
Raw Material Consumed
141.5448
0%
 
100
Raw Material Consumed
stock-recommendation Finished Goods
Finished Goods Dashboard stock-summary
Finished Goods
Amount(Rs Cr)
% of Sales Turnover
Tablets/Capsules/Syrups
80.61
99.99%
Job Work
0.01
0.01%
 
99.99
Tablets/Capsules/Syrups
0.01
Tablets/Capsules/Syrups
0.01
Job Work
99.99
Job Work
stock-recommendation Stock DNA
Revenue and Profits:
Net Sales:
0 Cr
(Quarterly Results - Sep 2025)
Net Profit:
0 Cr
stock-summary
Industry

Pharmaceuticals & Biotechnology

stock-summary
Market cap

INR 13 Cr (Micro Cap)

stock-summary
P/E

NA (Loss Making)

stock-summary
Industry P/E

34

stock-summary
Dividend Yield

0.00%

stock-summary
Debt Equity

0.47

stock-summary
Return on Equity

-74.62%

stock-summary
Price to Book

8.75